[In vitro and in vivo evaluation of inhibitory nucleic acid constructs for specific therapy of human urinary bladder carcinoma]

Urologe A. 2007 Sep;46(9):1289. doi: 10.1007/s00120-007-1499-y.

[Article in German]

Authors

D Kunze¹, S Füssel, A Meye, D Wuttig, K Krämer, M Kotzsch, M Toma, B Schwenzer, I Kausch, D Jocham, O W Hakenberg, M O Grimm, M P Wirth

Affiliation

¹ Klinik für Urologie, Medizinische Fakultät, Technische Universität Dresden, Fetscherstrasse 74, 01307 Dresden. Doreen.kunze@uniklinikum-dresden.de

PMID: 17665160
DOI: 10.1007/s00120-007-1499-y

No abstract available

MeSH terms

Animals
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Biomarkers, Tumor / genetics
Carcinoma, Transitional Cell / drug therapy*
Carcinoma, Transitional Cell / genetics
Carcinoma, Transitional Cell / pathology
Cell Division / drug effects
Gene Expression Regulation, Neoplastic / drug effects
Humans
In Vitro Techniques
Neoplasm Transplantation
Oligodeoxyribonucleotides, Antisense / therapeutic use*
RNA, Small Interfering / therapeutic use*
Tumor Cells, Cultured / drug effects*
Urinary Bladder Neoplasms / drug therapy*
Urinary Bladder Neoplasms / genetics
Urinary Bladder Neoplasms / pathology

Substances

Biomarkers, Tumor
Oligodeoxyribonucleotides, Antisense
RNA, Small Interfering